Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ADVB

Advanced Biomed Inc

5.20

Jul 15 • 03:59PM ET +0.11 (2.16%)

5.22

Aftermarket • 04:15PM ET +0.02 (0.39%)

Healthcare Diagnostics & Research Taiwan Nano NASD

Peers: BIAF ISPC NDRA NOTV MBAI XWEL MDXH PRPO QUCY XGN

Scroll to Statements

Index	-
Market Cap	8.59M
Enterprise Value	8.53M
Income	0.17M
Sales	0.00M
Book/sh	0.21
Cash/sh	0.05
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	31
IPO	Mar 06, 2025

P/E	32.66
Forward P/E	-
PEG	-
P/S	-
P/B	24.95
P/C	107.39
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	7.38
Current Ratio	7.38
Debt/Eq	0.07
LT Debt/Eq	0.00
Option/Short	No / Yes

EPS (ttm)	0.16
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	10.67% -12.01%
Sales past 3/5Y	- -
EPS Y/Y TTM	271.18%
Sales Y/Y TTM	-
EPS Q/Q	69.15%
Sales Q/Q	-
Earnings	-
EPS/Sales Surpr.	- -

Insider Own	78.92%
Insider Trans	0.00%
Inst Own	0.08%
Inst Trans	-0.01%
ROA	59.90%
ROE	84.61%
ROIC	58.89%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	4.65%
SMA50	8.08%
SMA200	-16.28%
Trades

Shs Outstand	1.38M
Shs Float	0.35M
Short Float	4.40%
Short Ratio	0.12
Short Interest	0.02M
52W High	17.46 -70.22%
52W Low	3.61 44.04%
Volatility	12.38% 10.63%
ATR (14)	0.53
RSI (14)	55.97
Beta	0.36
Rel Volume	0.02
Avg Volume	125.68K
Volume	3,107

Perf Week	3.17%
Perf Month	15.55%
Perf Quarter	-17.59%
Perf Half Y	-27.31%
Perf YTD	-10.90%
Perf Year	-67.49%
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	-
Target Price	-
Prev Close	5.09
Price	5.20
Change	2.16%

Feb-18-26 07:00AM	Advanced Biomed Inc. Announces 1 for 20 Share Consolidation (GlobeNewswire) -10.69%
Feb-13-26 08:00AM	Advanced Biomed Inc. Announces 120-Case Feasibility Study with Chi-Mei Medical Center to Validate A+PerfusC - Integrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug Discovery (GlobeNewswire)
Dec-31-25 10:25AM	Advanced Biomed sells Hong Kong subsidiary for $23,000 (TipRanks) -13.82%
Dec-30-25 10:17AM	Advanced Biomed Inc. Announces Disposal of its Hong Kong Subsidiary (GlobeNewswire)
Sep-19-25 08:30AM	Advanced Biomed Inc. Announces Launch of A+PerfusC - Integrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug Discovery (GlobeNewswire) -17.18%
12:29PM	Loading…
Mar-07-25 12:29PM	Advanced Biomed Inc. Announces Closing Of US$6.56 Million Initial Public Offering (GlobeNewswire)
Mar-06-25 09:02AM	Advanced Biomed Inc. Announces Pricing of Initial Public Offering (GlobeNewswire)

Advanced Biomed, Inc. operates as a holding company with interests in developing biochip technologies. It engages in the research & development of microfluidic biochip technologies and provides tumor diagnosis and treatment technology applications. The company was founded by Yi Lu and Steven I-Fang Cheng in 2014 and is headquartered in Tainan, Taiwan.

CFO & DirectorMr. Mingze Yin

CEO & ChairmanMr. Xiaomin Chen Ph.D.

Director of Investor Relations- Alan

SecretaryDr. Hung To Pau Ph.D.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ADVB

Advanced Biomed Inc

Upgrade your Finviz experience